Pharmafile Logo
Pharmafocus logo
Advanced Search

cellectis

Showing 6 posts of 6 posts found.

AstraZeneca and Cellectis to collaborate for cell therapy and genomic medicine development

November 1, 2023
Research and Development AstraZeneca, CGT, Pharmacy, cell therapy, cellectis, genomic medicine

AstraZeneca has announced a collaboration and investment agreement with Cellectis for the development of next generation cell and gene therapeutics …

News
cellectis

Cellectis given another shot at off-the-shelf CAR-T

November 8, 2017
Medical Communications, Research and Development CAR-T, biotech, cellectis, drugs, pharma, pharmaceutical

It is easy to forget the very real dangers that CAR-T treatment present to patients after Novartis and Gilead both …

News

FDA halts trial after first CAR T-associated patient death

September 6, 2017
Research and Development CAR T, CAR-T, Cancer, FDA, cellectis, leukaemia, patient death, pharma, pharmaceutical

French clinical-stage biopharma firm Cellectis has received an order from the FDA to halt its study of CAR T therapy …

News
Servier image

Servier signs leukaemia deal

February 19, 2014
Research and Development, Sales and Marketing Servier, UCART19, car, cellectis, leaukaemia

French firms Servier and small biopharma cancer specialist Cellectis have signed a deal to develop and commercialise one drug targeting …

News

Contract research news in brief

October 15, 2010
Research and Development Clinipace, Covance, PPD, Quintiles, Synexus, cellectis

Our latest crop of contract research news includes updates from Clinipace, PPD, Cellectis bioresearch, Covance, Quintiles and Synexus. US contract …

News
Cellectis Sylvie

Cellectis appoints Dr Sylvie Delassus Senior Vice President Communications

October 20, 2009
Research and Development appointment, cellectis, research and development

French genome engineering company Cellectis has appointed Dr Sylvie Delassus senior vice president communications and a member of its executive …

Appointment

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024